http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
최용환(Choi Yong Hwan) 한국갈등관리학회 2014 한국갈등관리연구 Vol.1 No.1
이 연구는 충북혁신도시의 사례에서 직면하고 있는 조성과정의 갈등의 문제를 해결하고 상생발전을 분석하는 데 초점을 두고 있다. 2012년에 완성에 하기로 하였던 충북혁신도시의 건설은 혁신지향적 발전패러다임에 근거를 둔 지역발전중의 하나이다. 본 연구는 지방정부와 이전 공공기관사이의 연계를 분석과 함께 충북혁신도시에 중심으로 상생협력전략의 연계를 위한 방안을 제시하였다. 충북혁신도시는 혁신지향적 발전 패러다임에 근거를 둔 지역발전전략 중의 하나이다. 충북혁신도시는 지역발전을 위한 큰 기회를 가지고 있다. 첫째, 충북혁신도시는 이전공공기관과 지역산업과 연계를 해야 성공할 수 있다. 둘째, 충북혁신도시는 전반에 대해 권한과 책임을 갖고 사업을 시행할 수 있는 행정체제를 구축할 필요가 있다. 셋째, 이전 공공기관의 지역에 대한 이해와 공감대가 형성되어야 한다. 그러므로 본 연구는 충북혁신도시를 사례로 혁신도시와 연계한 충북의 전략산업 중심의 산학연계 구축방안 모색을 통하여 지역의 상생발전방안을 제시하였다. This study focuses to analyze the win-win development and to solve the problem of conflict facing the construction process in the case of chungbuk innovation city. Focused on completion in 2012 Chungbuk innovation city is one of the regional development strategies, which is based on the paradigm of innovation-driven development. Chungbuk innovation city has a great opportunities for the development. So we can facilitate local development, It is important to be able to build a city of innovation. In the course of developing the city of innovation, First, Chungbuk Innovative City can do a success in connection with the public and the local industry. Second, Chungbuk innovation city is a need to build the administrative system have that it can be implemented the authority and responsibility for projects. Third, the previous public agency should be with an understanding and consensus in the area. The plan must be linked to regional strategic industries. Therefore, This study presented the methods for linkage between regional industries and public organizations relocated to local regions
간장 ( 肝臟 ) 및 담도 ( 膽道 ) : 간경변증을 동반한 간암 환자에 있어서 혈청 Complement의 진단적 의의
최용환(Yong Hwan Choi),김성록(Sung Rok Kim),곽규식(Kyu Sik Kwak),박재용(Jae Yong Park),김은영(Eun Young Kim),정준모(Jun Mo Chung),탁원영(Won Young Tak),송달효(Dal Hyo Song) 대한소화기학회 1990 대한소화기학회지 Vol.22 No.4
N/A To evaluate the diagnostic accuracy of serum complement level as an early diagnostic tool of hepatocellular carcinoma in cirrhotic patient, we examined 22 cases of liver cirrhosis and 16 cases of liver cirrhosie with hepatocellular carcinama. The results are as follows; 1) In liver cirrhosis with hepatocellular carcinoma, serum complement level was higher than liver cirrhosis. 2) When the serum cornplement levels, C3; 61 mg/dl and C4; 41 mg/dl, were indicated as the cutoff value in differential diagnosis of liver cirrhosis and hepatocellular carcinoma with liver cirrhosis, the poeitive predictive value, negative predictive value, and accuracy were 90%, 75%, and 79%, respectively. 3) When in serum AFP level, the cutoff value was disclosed as 400 ng/ml, the positive predictive value, negative predictive value, and accuracy of serum alpha fetoprotein were 100%, 31%, and 74% respectively, 4) Considering combination of above described data of serum C3, C4 and AFP, the positive predietive value, negative predictive value, accuracy were 92%, 81%, 84% respectively. Based on these data, serum complement level may be used as a valuable tumor marker in the die oais of hepatocellular carcinoma in cirrhotic patient eapecially when it is considered together with rum alpha fetoprotein level.
최용환(Yong Hwan Choi),곽규식(Kyu Sik Kwak),정준모(Jun Mo Jung),이경수(Kyung Su Lee),박재용(Jae Yong Park),김은영(Eun Young Kim) 대한소화기학회 1989 대한소화기학회지 Vol.21 No.2
N/A For evaluating the efficacy of teprenone for gastric ulcer, we prescribed 50 mg of teprenone orally three times daily for 16 gastric ulcer patients and done follow up studies including gastric and biochemical tests. The results obtained were as follows: 1) Gastroscopic examination revealed remarkable improvement in 31.3% and moderate improvement in 25.0% of patients during 8 weeks. 2) Subjective symptoms such as epigastric pain, nausea, vomiting, anorexia and belching were subsided from 68.8% to 100% of patients. 3) No remarkable side effect were noted. These results suggest that teprenone is one of effective therapeutic drugs for gastric ulcer patients.